Alice C O'Farrell

9PUBLICATIONS
50CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 04, 2026
Bevacizumab for Metastatic Colorectal Cancer with Chromosomal Instability: Cost-Effectiveness Analysis for a Novel Precision Treatment Approach in Germany, Ireland and Spain.

Jonathan Briody, Ian S Miller, James F O'Mahony

|Nov 14, 2023
Genomic Exploration of Distinct Molecular Phenotypes Steering Temozolomide Resistance Development in Patient-Derived Glioblastoma Cells.

Federica Fabro, Trisha V Kers, Kate J Feller

|Aug 24, 2021
Molecular Subtyping Combined with Biological Pathway Analyses to Study Regorafenib Response in Clinically Relevant Mouse Models of Colorectal Cancer.

Adam Lafferty, Alice C O'Farrell, Giorgia Migliardi

|Jan 08, 2021
Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts.

Xing Yi Woo, Jessica Giordano, Anuj Srivastava

|Oct 17, 2020
Implementing Systems Modelling and Molecular Imaging to Predict the Efficacy of BCL-2 Inhibition in Colorectal Cancer Patient-Derived Xenograft Models.

Alice C O'Farrell, Monika A Jarzabek, Andreas U Lindner

|Sep 29, 2018
Author Correction: Anti-angiogenic drug scheduling optimisation with application to colorectal cancer.

M Sturrock, I S Miller, G Kang

Pageof 2

Frequent Collaborators

4 joint publications

Diether Lambrechts

3 joint publications

Ian S Miller

3 joint publications

Enzo Medico

2 joint publications

Kate Connor